🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Hyperosmotic agents are used to decrease intracranial pressure. The aim of ...
Status
Unknown
Location
Multiple Locations
Start Date
2020-04
Trial ID
NCT04314674
Treatments Being Tested
Stroke remains the fourth leading cause of death in the United States (seco...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-09
Trial ID
NCT01954290
Treatments Being Tested
Cerebral edema is seen heterogenous group of neurological disease states th...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01605357
This is a pragmatic, multicenter, interventional, parallel-arm, randomized,...
Status
Completed
Location
University Hospital Brussels
Start Date
2022-06-12
Trial ID
NCT05411991
Treatments Being Tested
This proposal will measure the effects of mannitol administration versus pl...
Status
Completed
Location
Brigham and Women's
Start Date
2021-04-06
Trial ID
NCT04428372
Treatments Being Tested
Patients with high aldosterone hormone have higher blood glucose than norma...
Status
Withdrawn
Location
UT Southwestern Medical Center
Start Date
2010-11
Trial ID
NCT02102243
Elevated intracranial pressure (ICP) is one of the most common symptoms enc...
Status
Completed
Location
Cairo university
Start Date
2020-12-21
Trial ID
NCT04686344
Treatments Being Tested
With over one million operations a year, cardiac surgery with cardiopulmona...
Status
Terminated
Location
Austin Health
Start Date
2008-05
Trial ID
NCT00672334
Treatments Being Tested
This study examines the role of osmotic agents in controlling brain swellin...
Status
Terminated
Location
University Hospital
Start Date
2010-04
Trial ID
NCT01111682
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy of early continuou...
Status
Recruiting
Location
CHU d'Angers
Start Date
2026-04-21
Trial ID
NCT07319208
Treatments Being Tested